Skip to Content


Prospective Grant of Exclusive License: P2X7

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

A notice published in the August 29, 2002 Federal Register—announcing the prospective grant of an exclusive license for the use of P2X7 receptor antagonists (67 FR 55415)—incorrectly listed the receipt date for comments/license applications as “October 28, 2002” under the DATES section. This notice serves to correct the date to reflect a 90-day review period rather than a 60-day review period. To allow interested parties adequate time to respond, NIH is publishing this notice to amend the DATES: section to read: “Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before December 12, 2002, will be considered.”

Start Signature

Dated: September 3, 2002.

Jack Spiegel,

Director, Division of Technology Development and Transfer, Office of Technology Transfer.

End Signature End Preamble

[FR Doc. 02-23333 Filed 9-12-02; 8:45 am]